Cyrus Biotechnology, Inc.

Form D Filings

Location
Seattle, WA
Industry Group
Biotechnology
Related People
Lucas Nivon, Mark Benjamin, Yifan Song, Chad Waite, Anthony Manning, Ramakrishna Satyavolu, Jason Smith, Gus Tai, Eric Bell, Javier Castellanos, Nivon Lucas
Entity Type
Corporation
CIK
0001641241
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
7/15/2025 Option to Acquire, Security to be Acquired $1,110,000 $1,110,000 $1,500,000 $390,000 7/1/2025 7/15/2025 D 000164124125000003
12/30/2024 Option to Acquire, Security to be Acquired $3,183,997 $3,183,997 $3,500,000 $316,003 10/29/2024 12/30/2024 D 000164124124000003
2/28/2024 Debt, Option to Acquire, Security to be Acquired $2,694,470 $2,694,470 $4,000,000 $1,305,530 2/27/2024 2/28/2024 D 000164124124000002
12/2/2021 Equity $2,410,524 $18,352,692 $19,352,692 $1,000,000 6/22/2021 12/1/2021 D/A 000164124121000003
10/6/2021 Equity $6,840,411 $15,942,168 $15,942,168 $0 6/22/2021 10/5/2021 D/A 000164124121000002
7/7/2021 Equity $9,101,757 $9,101,757 $12,942,155 $3,840,398 6/22/2021 7/6/2021 D 000164124121000001
9/17/2020 Debt $1,131,000 $1,131,000 $1,500,000 $369,000 9/4/2020 9/17/2020 D 000164124120000001
7/27/2017 Equity $8,024,611 $8,024,611 $8,045,000 $20,389 7/13/2017 7/27/2017 D 000164124117000002
2/21/2017 Equity $1,040,000 $1,040,000 $1,250,000 $210,000 2/13/2017 2/17/2017 D 000164124117000001
11/16/2016 Equity, Other $490,000 $490,000 $500,000 $10,000 11/7/2016 11/16/2016 D 000164124116000003
4/6/2016 Debt, Other $535,000 $535,000 $575,000 $40,000 3/23/2016 4/5/2016 D 000164124116000002
5/6/2015 Debt $850,000 $850,000 $850,000 $0 4/22/2015 5/6/2015 D 000164124115000001